USD835258S1 - Pharmaceutical tablet - Google Patents

Pharmaceutical tablet Download PDF

Info

Publication number
USD835258S1
USD835258S1 US29/637,070 US201829637070F USD835258S US D835258 S1 USD835258 S1 US D835258S1 US 201829637070 F US201829637070 F US 201829637070F US D835258 S USD835258 S US D835258S
Authority
US
United States
Prior art keywords
pharmaceutical tablet
view
elevational view
tablet
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/637,070
Inventor
Darshan Parikh
Scott Burnside
Sreenivas S. Bhat
Jiping Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to US29/637,070 priority Critical patent/USD835258S1/en
Application granted granted Critical
Publication of USD835258S1 publication Critical patent/USD835258S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top perspective view of a pharmaceutical tablet in accordance with the present design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a side elevational view thereof;
FIG. 5 is the opposite side elevational view thereof;
FIG. 6 is an end elevational view thereof;
FIG. 7 is the opposite end elevational view thereof;
FIG. 8 is a top perspective view of a pharmaceutical tablet in accordance with a second embodiment of the present design;
FIG. 9 is a top plan view thereof;
FIG. 10 is a bottom plan view thereof;
FIG. 11 is a side elevational view thereof;
FIG. 12 is the opposite side elevational view thereof;
FIG. 13 is an end elevational view thereof; and,
FIG. 14 is the opposite end elevational view thereof.
Portions of the tablet are shown in broken lines to indicate that those portions form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a pharmaceutical tablet, as shown and described.
US29/637,070 2017-02-22 2018-02-13 Pharmaceutical tablet Active USD835258S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/637,070 USD835258S1 (en) 2017-02-22 2018-02-13 Pharmaceutical tablet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29/594,820 USD813372S1 (en) 2017-02-22 2017-02-22 Pharmaceutical tablet
US29/637,070 USD835258S1 (en) 2017-02-22 2018-02-13 Pharmaceutical tablet

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US29/594,820 Continuation USD813372S1 (en) 2017-02-22 2017-02-22 Pharmaceutical tablet

Publications (1)

Publication Number Publication Date
USD835258S1 true USD835258S1 (en) 2018-12-04

Family

ID=61599827

Family Applications (2)

Application Number Title Priority Date Filing Date
US29/594,820 Active USD813372S1 (en) 2017-02-22 2017-02-22 Pharmaceutical tablet
US29/637,070 Active USD835258S1 (en) 2017-02-22 2018-02-13 Pharmaceutical tablet

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US29/594,820 Active USD813372S1 (en) 2017-02-22 2017-02-22 Pharmaceutical tablet

Country Status (3)

Country Link
US (2) USD813372S1 (en)
AU (1) AU201714443S (en)
CA (1) CA176577S (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine
US11466278B2 (en) 2016-11-01 2022-10-11 Novo Nordisk A/S Temperature based plasmid regulation system

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD301764S (en) 1987-12-21 1989-06-20 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD302051S (en) 1987-12-21 1989-07-04 Rorer Pharmaceutical Corporation Pharmaceutical tablet
US5770225A (en) 1989-04-28 1998-06-23 Mcneil-Ppc, Inc. Process of preparing a subcoated simulated capsule-like medicament
US5824338A (en) 1996-08-19 1998-10-20 L. Perrigo Company Caplet and gelatin covering therefor
USD403396S (en) 1996-11-28 1998-12-29 Astra Aktiebolag Tablet
USD425614S (en) * 1999-04-16 2000-05-23 Merck & Co., Inc. Tablet
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
US6165513A (en) 1997-06-11 2000-12-26 The Procter & Gamble Co. Film-coated tablet for improved upper gastrointestinal tract safety
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD506544S1 (en) 2004-01-13 2005-06-21 Roger A. Rinker Medicinal tablet
USD515202S1 (en) 2004-07-19 2006-02-14 Merck & Co., Inc Tablet
USD534646S1 (en) 2006-01-06 2007-01-02 Access Business Group International Llc Nutritional supplement tablet
USD535021S1 (en) 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
USD564086S1 (en) 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD671636S1 (en) 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD771236S1 (en) * 2015-12-15 2016-11-08 Johnson & Johnson Consumer Inc. Tablet
USD787043S1 (en) 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787042S1 (en) 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet

Patent Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD301764S (en) 1987-12-21 1989-06-20 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD302051S (en) 1987-12-21 1989-07-04 Rorer Pharmaceutical Corporation Pharmaceutical tablet
US5770225A (en) 1989-04-28 1998-06-23 Mcneil-Ppc, Inc. Process of preparing a subcoated simulated capsule-like medicament
US5824338A (en) 1996-08-19 1998-10-20 L. Perrigo Company Caplet and gelatin covering therefor
USD403396S (en) 1996-11-28 1998-12-29 Astra Aktiebolag Tablet
USD408910S (en) 1996-11-28 1999-04-27 Astra Aktiebolag Tablet
US6165513A (en) 1997-06-11 2000-12-26 The Procter & Gamble Co. Film-coated tablet for improved upper gastrointestinal tract safety
USD425614S (en) * 1999-04-16 2000-05-23 Merck & Co., Inc. Tablet
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD506544S1 (en) 2004-01-13 2005-06-21 Roger A. Rinker Medicinal tablet
USD515202S1 (en) 2004-07-19 2006-02-14 Merck & Co., Inc Tablet
USD535021S1 (en) 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
USD564086S1 (en) 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD534646S1 (en) 2006-01-06 2007-01-02 Access Business Group International Llc Nutritional supplement tablet
USD671636S1 (en) 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD787042S1 (en) 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD771236S1 (en) * 2015-12-15 2016-11-08 Johnson & Johnson Consumer Inc. Tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
U.S. Appl. No. 29/531,123, filed Jun. 23, 2015, Parikh et al.
United Stapes Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,123, dated Oct. 18, 2016.
United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/524,022, dated Oct. 18, 2016.
United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/525,253, dated Oct. 18, 2016.
United States Patent and Trademark Office, Final Office Action issued in U.S. Appl. No. 29/531,113, dated Oct. 18, 2016.
United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/525,253, dated Jan. 13, 2017.
United States Patent and Trademark Office, Notice of Allowance issued in U.S. Appl. No. 29/531,113, dated Jan. 17, 2017.
United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Apr. 6, 2016.
United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/524,022, dated Jan. 10, 2017.
United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/525,253, dated Apr. 11, 2016.
United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,113, dated Apr. 12, 2016.
United States Patent and Trademark Office, Office Action issued in U.S. Appl. No. 29/531,123, dated Apr. 11, 2016.

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11466278B2 (en) 2016-11-01 2022-10-11 Novo Nordisk A/S Temperature based plasmid regulation system
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine

Also Published As

Publication number Publication date
USD813372S1 (en) 2018-03-20
AU201714443S (en) 2017-09-04
CA176577S (en) 2018-03-26

Similar Documents

Publication Publication Date Title
USD825964S1 (en) Table
USD845132S1 (en) Cosmetic bottle
USD815945S1 (en) Cap
USD785617S1 (en) Tablet computer
USD769124S1 (en) Bottle
USD778460S1 (en) Vial
USD800732S1 (en) Electronic device shell
USD763857S1 (en) Electronic device shell
USD858741S1 (en) Pharmaceutical tablet
USD760844S1 (en) Gameboard
USD835258S1 (en) Pharmaceutical tablet
USD766820S1 (en) Battery
USD771236S1 (en) Tablet
USD810313S1 (en) Vibrator
USD918377S1 (en) Tablet
USD849582S1 (en) Bracelet
USD944646S1 (en) Bottle
USD771831S1 (en) Wand
USD751428S1 (en) Torpedo level
USD910474S1 (en) Adjustable bracelet
USD789211S1 (en) Container
USD723450S1 (en) Truck topper
USD862747S1 (en) Lightbulb
USD786085S1 (en) Bottle
USD787042S1 (en) Pharmaceutical tablet

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY